Early detection of hip dysplasia in newborn infants can prevent the need for surgical intervention in more than 98% of cases [2].

This medical priority matters because hip dysplasia is a congenital skeletal alteration of the hip joint that can lead to permanent mobility issues if left untreated. Identifying the condition in the first weeks or months of life allows doctors to implement non-surgical treatments that stabilize the joint.

The condition is relatively common among infants. Reports indicate that hip dysplasia affects approximately one in 20 babies [1]. Because the alteration is present at birth, medical professionals said the importance of screening during the neonatal period ensures the hip joint is properly formed.

Medical reports from Spain and Colombia highlight the effectiveness of early screening [1], [3]. When detected early, the vast majority of infants can be treated without invasive procedures. Without this early intervention, the condition can lead to symptoms such as pain, and limping as the child grows [2].

Pediatric orthopedists typically use screening tools to identify whether the hip joint is unstable. Because the condition is congenital, these checks are integrated into newborn care to catch skeletal irregularities before they progress. The goal is to ensure the femoral head remains securely seated in the acetabulum during the critical early stages of growth.

Treatment for those diagnosed early typically involves non-surgical methods. These interventions are designed to guide the joint into the correct position, effectively eliminating the need for surgery in over 98% of identified cases [2].

Hip dysplasia affects approximately one in 20 babies.

The high success rate of non-surgical intervention underscores the necessity of universal neonatal screening. By shifting the medical focus from corrective surgery to early detection, healthcare systems can significantly reduce long-term morbidity and the financial burden of complex orthopedic procedures for families.